Listed private equity investor HGL has bought an importer and distributor of pharmacy products and promotional solutions, taking advantage of a succession problem at the business to grab a controlling stake.

HGL will pay $5 million for the Sydney-based AMCLA and will install its own candidate, Charles Nightingale, as chief executive, giving him a maiden 20 per cent stake in the group and an option to move up to 40 per cent.